In vitro induced regulatory T cells are unique from endogenous regulatory T cells and effective at suppressing late stages of ongoing autoimmunity.
Strategies to boost the numbers and functions of regulatory T cells (Tregs) are currently being tested as means to treat autoimmunity. While Tregs have been shown to be effective in this role, strategies to manipulate Tregs to effectively suppress later stages of ongoing diseases need to be establis...
Main Authors: | Thanh-Long M Nguyen, Nabil T Makhlouf, Bryan A Anthony, Ryan M Teague, Richard J DiPaolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4131893?pdf=render |
Similar Items
-
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
by: Sarantis Korniotis, et al.
Published: (2016-07-01) -
Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes
by: Jingli Lu, et al.
Published: (2017-09-01) -
The role of regulatory T cells in autoimmune thyroiditis
by: S. I. Zhukova, et al.
Published: (2021-01-01) -
REGULATORY T-CELLS IN CHILDREN WITH AUTOIMMUNE DISEASES
by: I. A. Pashnina
Published: (2014-08-01) -
The role of regulatory T cells in the prevention of autoimmunity
by: Amorim Garcia da Rosa, Catarina Alexandre
Published: (1999)